Belpointe Asset Management LLC Buys New Holdings in Balchem Co. (NASDAQ:BCPC)

Belpointe Asset Management LLC bought a new stake in shares of Balchem Co. (NASDAQ:BCPC – Get Rating) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 544 shares of the basic materials company’s stock, valued at approximately $66,000.

Several other institutional investors also recently bought and sold shares of BCPC. Citigroup Inc. boosted its holdings in Balchem by 6.2% during the 1st quarter. Citigroup Inc. now owns 28,640 shares of the basic materials company’s stock valued at $3,915,000 after acquiring an additional 1,661 shares during the period. Natixis Advisors L.P. raised its position in Balchem by 4.9% during the 1st quarter. Natixis Advisors L.P. now owns 11,409 shares of the basic materials company’s stock valued at $1,560,000 after purchasing an additional 533 shares during the last quarter. MetLife Investment Management LLC raised its position in Balchem by 55.3% during the 1st quarter. MetLife Investment Management LLC now owns 17,389 shares of the basic materials company’s stock valued at $2,377,000 after purchasing an additional 6,189 shares during the last quarter. Rhumbline Advisers raised its position in shares of Balchem by 22.8% in the 1st quarter. Rhumbline Advisers now owns 96,068 shares of the basic materials company’s stock worth $13,132,000 after acquiring an additional 17,824 shares in the last quarter. Finally, BlackRock Inc. raised its position in shares of Balchem by 1.0% in the 1st quarter. BlackRock Inc. now owns 4,890,972 shares of the basic materials company’s stock worth $668,595,000 after acquiring an additional 46,959 shares in the last quarter. 89.29% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Balchem news, Director David B. Fischer sold 3,000 shares of the firm’s stock in a transaction dated Monday, March 20th. The stock was sold at an average price of $127.01, for a total transaction of $381,030.00. Following the sale, the director now directly owns 17,269 shares of the company’s stock, valued at $2,193,335.69. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other Balchem news, Director David B. Fischer sold 3,000 shares of the firm’s stock in a transaction dated Monday, March 20th. The stock was sold at an average price of $127.01, for a total transaction of $381,030.00. Following the sale, the director now directly owns 17,269 shares of the company’s stock, valued at $2,193,335.69. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Michael Robert Sestrick sold 2,300 shares of Balchem stock in a transaction dated Tuesday, May 2nd. The stock was sold at an average price of $130.36, for a total value of $299,828.00. Following the completion of the sale, the senior vice president now directly owns 5,424 shares in the company, valued at $707,072.64. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Analyst Ratings Changes

Several analysts recently weighed in on the company. StockNews.com assumed coverage on Balchem in a research note on Thursday. They issued a “hold” rating on the stock. HC Wainwright cut their target price on Balchem from $152.00 to $140.00 in a research note on Monday, February 27th.

Balchem Stock Performance

BCPC stock opened at $124.17 on Monday. The company has a market cap of $4.00 billion, a P/E ratio of 40.58 and a beta of 0.70. Balchem Co. has a 1 year low of $110.15 and a 1 year high of $143.88. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.88 and a quick ratio of 1.81. The stock’s fifty day moving average price is $126.47 and its 200-day moving average price is $129.83.

Balchem (NASDAQ:BCPC – Get Rating) last released its quarterly earnings results on Friday, April 28th. The basic materials company reported $0.70 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.78 by ($0.08). Balchem had a return on equity of 10.69% and a net margin of 10.48%. The firm had revenue of $232.54 million during the quarter, compared to analysts’ expectations of $232.00 million. During the same quarter last year, the business earned $0.89 earnings per share. On average, equities analysts forecast that Balchem Co. will post 3.6 earnings per share for the current year.

About Balchem

(Get Rating)

Balchem Corp. provides marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, Specialty Products and Industrial Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems.